S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit

ABSTRACT The high susceptibility of humans to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the cause of coronavirus disease 2019 (COVID-19), reflects the novelty of the virus and limited preexisting B cell immunity. IgG against the SARS-CoV-2 spike (S) protein, which carri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Phuong Nguyen-Contant, A. Karim Embong, Preshetha Kanagaiah, Francisco A. Chaves, Hongmei Yang, Angela R. Branche, David J. Topham, Mark Y. Sangster
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/0999ec747b4f4a81a0fdcfbb69764096
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0999ec747b4f4a81a0fdcfbb69764096
record_format dspace
spelling oai:doaj.org-article:0999ec747b4f4a81a0fdcfbb697640962021-11-15T16:19:07ZS Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit10.1128/mBio.01991-202150-7511https://doaj.org/article/0999ec747b4f4a81a0fdcfbb697640962020-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01991-20https://doaj.org/toc/2150-7511ABSTRACT The high susceptibility of humans to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the cause of coronavirus disease 2019 (COVID-19), reflects the novelty of the virus and limited preexisting B cell immunity. IgG against the SARS-CoV-2 spike (S) protein, which carries the novel receptor binding domain (RBD), is absent or at low levels in unexposed individuals. To better understand the B cell response to SARS-CoV-2 infection, we asked whether virus-reactive memory B cells (MBCs) were present in unexposed subjects and whether MBC generation accompanied virus-specific IgG production in infected subjects. We analyzed sera and peripheral blood mononuclear cells (PBMCs) from non-SARS-CoV-2-exposed healthy donors and COVID-19 convalescent subjects. Serum IgG levels specific for SARS-CoV-2 proteins (S, including the RBD and S2 subunit, and nucleocapsid [N]) and non-SARS-CoV-2 proteins were related to measurements of circulating IgG MBC levels. Anti-RBD IgG was absent in unexposed subjects. Most unexposed subjects had anti-S2 IgG, and a minority had anti-N IgG, but IgG MBCs with these specificities were not detected, perhaps reflecting low frequencies. Convalescent subjects had high levels of IgG against the RBD, S2, and N, together with large populations of RBD- and S2-reactive IgG MBCs. Notably, IgG titers against the S protein of the human coronavirus OC43 were higher in convalescent subjects than in unexposed subjects and correlated strongly with anti-S2 titers. Our findings indicate cross-reactive B cell responses against the S2 subunit that might enhance broad coronavirus protection. Importantly, our demonstration of MBC induction by SARS-CoV-2 infection suggests that a durable form of B cell immunity is maintained even if circulating antibody levels wane. IMPORTANCE The recent rapid worldwide spread of SARS-CoV-2 has established a pandemic of potentially serious disease in the highly susceptible human population. Key issues are whether humans have preexisting immune memory that provides some protection against SARS-CoV-2 and whether SARS-CoV-2 infection generates lasting immune protection against reinfection. Our analysis focused on pre- and postinfection IgG and IgG memory B cells (MBCs) reactive to SARS-CoV-2 proteins. Most importantly, we demonstrate that infection generates both IgG and IgG MBCs against the novel receptor binding domain and the conserved S2 subunit of the SARS-CoV-2 spike protein. Thus, even if antibody levels wane, long-lived MBCs remain to mediate rapid antibody production. Our study results also suggest that SARS-CoV-2 infection strengthens preexisting broad coronavirus protection through S2-reactive antibody and MBC formation.Phuong Nguyen-ContantA. Karim EmbongPreshetha KanagaiahFrancisco A. ChavesHongmei YangAngela R. BrancheDavid J. TophamMark Y. SangsterAmerican Society for MicrobiologyarticleCOVID-19IgG antibodiesmemory B cellsSARS-CoV-2spike proteinMicrobiologyQR1-502ENmBio, Vol 11, Iss 5 (2020)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
IgG antibodies
memory B cells
SARS-CoV-2
spike protein
Microbiology
QR1-502
spellingShingle COVID-19
IgG antibodies
memory B cells
SARS-CoV-2
spike protein
Microbiology
QR1-502
Phuong Nguyen-Contant
A. Karim Embong
Preshetha Kanagaiah
Francisco A. Chaves
Hongmei Yang
Angela R. Branche
David J. Topham
Mark Y. Sangster
S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
description ABSTRACT The high susceptibility of humans to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the cause of coronavirus disease 2019 (COVID-19), reflects the novelty of the virus and limited preexisting B cell immunity. IgG against the SARS-CoV-2 spike (S) protein, which carries the novel receptor binding domain (RBD), is absent or at low levels in unexposed individuals. To better understand the B cell response to SARS-CoV-2 infection, we asked whether virus-reactive memory B cells (MBCs) were present in unexposed subjects and whether MBC generation accompanied virus-specific IgG production in infected subjects. We analyzed sera and peripheral blood mononuclear cells (PBMCs) from non-SARS-CoV-2-exposed healthy donors and COVID-19 convalescent subjects. Serum IgG levels specific for SARS-CoV-2 proteins (S, including the RBD and S2 subunit, and nucleocapsid [N]) and non-SARS-CoV-2 proteins were related to measurements of circulating IgG MBC levels. Anti-RBD IgG was absent in unexposed subjects. Most unexposed subjects had anti-S2 IgG, and a minority had anti-N IgG, but IgG MBCs with these specificities were not detected, perhaps reflecting low frequencies. Convalescent subjects had high levels of IgG against the RBD, S2, and N, together with large populations of RBD- and S2-reactive IgG MBCs. Notably, IgG titers against the S protein of the human coronavirus OC43 were higher in convalescent subjects than in unexposed subjects and correlated strongly with anti-S2 titers. Our findings indicate cross-reactive B cell responses against the S2 subunit that might enhance broad coronavirus protection. Importantly, our demonstration of MBC induction by SARS-CoV-2 infection suggests that a durable form of B cell immunity is maintained even if circulating antibody levels wane. IMPORTANCE The recent rapid worldwide spread of SARS-CoV-2 has established a pandemic of potentially serious disease in the highly susceptible human population. Key issues are whether humans have preexisting immune memory that provides some protection against SARS-CoV-2 and whether SARS-CoV-2 infection generates lasting immune protection against reinfection. Our analysis focused on pre- and postinfection IgG and IgG memory B cells (MBCs) reactive to SARS-CoV-2 proteins. Most importantly, we demonstrate that infection generates both IgG and IgG MBCs against the novel receptor binding domain and the conserved S2 subunit of the SARS-CoV-2 spike protein. Thus, even if antibody levels wane, long-lived MBCs remain to mediate rapid antibody production. Our study results also suggest that SARS-CoV-2 infection strengthens preexisting broad coronavirus protection through S2-reactive antibody and MBC formation.
format article
author Phuong Nguyen-Contant
A. Karim Embong
Preshetha Kanagaiah
Francisco A. Chaves
Hongmei Yang
Angela R. Branche
David J. Topham
Mark Y. Sangster
author_facet Phuong Nguyen-Contant
A. Karim Embong
Preshetha Kanagaiah
Francisco A. Chaves
Hongmei Yang
Angela R. Branche
David J. Topham
Mark Y. Sangster
author_sort Phuong Nguyen-Contant
title S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
title_short S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
title_full S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
title_fullStr S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
title_full_unstemmed S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
title_sort s protein-reactive igg and memory b cell production after human sars-cov-2 infection includes broad reactivity to the s2 subunit
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/0999ec747b4f4a81a0fdcfbb69764096
work_keys_str_mv AT phuongnguyencontant sproteinreactiveiggandmemorybcellproductionafterhumansarscov2infectionincludesbroadreactivitytothes2subunit
AT akarimembong sproteinreactiveiggandmemorybcellproductionafterhumansarscov2infectionincludesbroadreactivitytothes2subunit
AT preshethakanagaiah sproteinreactiveiggandmemorybcellproductionafterhumansarscov2infectionincludesbroadreactivitytothes2subunit
AT franciscoachaves sproteinreactiveiggandmemorybcellproductionafterhumansarscov2infectionincludesbroadreactivitytothes2subunit
AT hongmeiyang sproteinreactiveiggandmemorybcellproductionafterhumansarscov2infectionincludesbroadreactivitytothes2subunit
AT angelarbranche sproteinreactiveiggandmemorybcellproductionafterhumansarscov2infectionincludesbroadreactivitytothes2subunit
AT davidjtopham sproteinreactiveiggandmemorybcellproductionafterhumansarscov2infectionincludesbroadreactivitytothes2subunit
AT markysangster sproteinreactiveiggandmemorybcellproductionafterhumansarscov2infectionincludesbroadreactivitytothes2subunit
_version_ 1718426947881533440